Neutrophil stunning by metoprolol reduces infarct size

Nature Communications

Volumn 8, Issue , 2017, Pages

  García Prieto, Jaime ^a,b   Villena Gutiérrez, Rocío ^a   Gómez, Mónica ^a   Bernardo, Esther ^c   Pun García, Andrés ^a   García Lunar, Inés ^a,b,d,e   Crainiciuc, Georgiana ^a   Fernández Jiménez, Rodrigo ^a,b,c   Sreeramkumar, Vinatha ^a,d   Bourio Martínez, Rafael ^a,f   García Ruiz, José M ^a,b,g   Del Valle, Alfonso Serrano ^a   Sanz Rosa, David ^a,b,d   Pizarro, Gonzalo ^a,b,d   Fernández Ortiz, Antonio ^a,b,c   Hidalgo, Andrés ^a,h   Fuster, Valentín ^a,i   Ibanez, Borja ^a,b,j  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b CIBERCV   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^e Hospital Universitario Quiron Madrid   (Spain)

^f HOSPITAL DE BASURTO   (Spain)

^g HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j UAM)   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; METOPROLOL; P SELECTIN GLYCOPROTEIN LIGAND 1; ADRB1 PROTEIN, HUMAN; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; MESSENGER RNA;

CARDIOVASCULAR DISEASE; CELLS AND CELL COMPONENTS; INJURY; PHYSIOLOGY; PROTEIN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; HEART INFARCTION SIZE; HEART PROTECTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION INHIBITION; MALE; MOUSE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTE; ANIMAL; CELL MOTION; CYTOLOGY; DRUG EFFECT; GENETICS; HEART INFARCTION; HEMATOPOIETIC STEM CELL; METABOLISM; PATHOLOGY; THROMBOCYTE AGGREGATION;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; CELL MOVEMENT; HEMATOPOIETIC STEM CELLS; HUMANS; METOPROLOL; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; PLATELET AGGREGATION; RECEPTORS, ADRENERGIC, BETA-1; RNA, MESSENGER;

EID: 85017497647     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14780     Document Type: Article

References (55)

1. Ibanez, B., Heusch, G., Ovize, M. & Van de Werf, F. Evolving therapies for myocardial ischemia/reperfusion injury. J. Am. Coll. Cardiol. 65, 1454-1471 (2015).
2. Hausenloy, D. J. & Yellon, D. M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123, 92-100 (2013).
3. Vinten-Johansen, J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 61, 481-497 (2004).
4. Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159-175 (2013).
5. Fernandez-Jimenez, R. et al. Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion. J. Am. Coll. Cardiol. 66, 816-828 (2015).
6. Huebener, P. et al. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J. Clin. Invest. 125, 539-550 (2015).
7. Li, J. et al. Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation. J. Clin. Invest. 124, 1483-1496 (2014).
8. Sreeramkumar, V. et al. Neutrophils scan for activated platelets to initiate inflammation. Science 346, 1234-1238 (2014).
9. Ibanez, B. et al. Effect of early metoprolol on infarct size in ST-segmentelevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial. Circulation 128, 1495-1503 (2013).
10. Pizarro, G. et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (effect of metoprolol in cardioprotection during an acute myocardial infarction). J. Am. Coll. Cardiol. 63, 2356-2362 (2014).
11. Antoniucci, D. Block the ischemia and reperfusion damage: an old adjunctive drug for a new reperfusion strategy. J. Am. Coll. Cardiol. 63, 2363-2364 (2014).
12. Marino, F. & Cosentino, M. Adrenergic modulation of immune cells: an update. Amino Acids 45, 55-71 (2013).
13. Flierl, M. A. et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449, 721-725 (2007).
14. Zieziulewicz, T. J., Mondal, T. K., Gao, D. & Lawrence, D. A. Stress-induced effects, which inhibit host defenses, alter leukocyte trafficking. Cell Stress Chaperones 18, 279-291 (2013).
15. Kim, M. H. et al. Catecholamine stress alters neutrophil trafficking and impairs wound healing by beta2-adrenergic receptor-mediated upregulation of IL-6. J. Invest. Dermatol. 134, 809-817 (2014).
16. Scanzano, A. et al. Adrenergic modulation of migration, CD11b and CD18 expression, ROS and interleukin-8 production by human polymorphonuclear leukocytes. Inflamm. Res. 64, 127-135 (2015).
17. Horn, N. A. et al. Epinephrine enhances platelet-neutrophil adhesion in whole blood in vitro. Anesth. analg. 100, 520-526 (2005).
18. Ibanez, B. et al. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARDCNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction. Am. Heart J. 164, 473-480 e475 (2012).
19. Eitel, I. et al. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 64, 1217-1226 (2014).
20. Barron, H. V., Cannon, C. P., Murphy, S. A., Braunwald, E. & Gibson, C. M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 102, 2329-2334 (2000).
21. O'Donoghue, M. et al. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. Eur. Heart J. 29, 984-991 (2008).
22. Palmerini, T. et al. Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial. Circulation 123, 2829-2837 (2011).
23. Chen, Y. et al. Cocaine and catecholamines enhance inflammatory cell retention in the coronary circulation of mice by upregulation of adhesion molecules. Am. j. physiol. Heart circ. physiol. 288, H2323-H2331 (2005).
24. Dhabhar, F. S., Malarkey, W. B., Neri, E. & McEwen, B. S. Stress-induced redistribution of immune cells - from barracks to boulevards to battlefields: a tale of three hormones - Curt Richter Award winner. Psychoneuroendocrinology 37, 1345-1368 (2012).
25. Epelman, S., Liu, P. P. & Mann, D. L. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat. rev. Immunol. 15, 117-129 (2015).
26. Jordan, J. E., Zhao, Z. Q. & Vinten-Johansen, J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 43, 860-878 (1999).
27. Looney, M. R. & Matthay, M. A. Neutrophil sandwiches injure the microcirculation. Nat. Med. 15, 364-366 (2009).
28. Casanova-Acebes, M. et al. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell 153, 1025-1035 (2013).
29. Lefer, D. J. Do neutrophils contribute to myocardial reperfusion injury? Basic Res. Cardiol. 97, 263-267 (2002).
30. Seo, J. K. et al. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J. Immunol. 158, 1895-1901 (1997).
31. Chen, Y. & Junger, W. G. Measurement of oxidative burst in neutrophils. Methods Mol. Biol. 844, 115-124 (2012).
32. Grisanti, L. A. et al. Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent. Mol. immunol. 47, 1244-1254 (2010).
33. Swirski, F. K. & Nahrendorf, M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339, 161-166 (2013).
34. Botto, N. et al. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for 'no-reflow' phenomenon? Int. J. cardiol. 117, 123-130 (2007).
35. Xiao, Z. & Theroux, P. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. J. Am. Coll. Cardiol. 43, 1982-1988 (2004).
36. van Velzen, J. F., Laros-van Gorkom, B. A., Pop, G. A. & van Heerde, W. L. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers. Thromb. Res. 130, 92-98 (2012).
37. Giacomazzi, A., Degan, M., Calabria, S., Meneguzzi, A. & Minuz, P. Antiplatelet agents inhibit the generation of platelet-derived microparticles. Front. Pharmacol. 7, 314 (2016).
38. Ndrepepa, G. & Kastrati, A. Intravenous beta-blockers in primary percutaneous coronary intervention: new hope for an old therapy. Circulation 128, 1487-1489 (2013).
39. Mateos, A. et al. Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial. Ann. Emerg. Med. 65, 318-324 (2015).
40. Ibanez, B. et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 115, 2909-2916 (2007).
41. Ibanez, B. et al. The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int. J. Cardiol. 147, 428-432 (2011).
42. Eltzschig, H. K. & Eckle, T. Ischemia and reperfusion - from mechanism to translation. Nat. Med. 17, 1391-1401 (2011).
43. Phillipson, M. & Kubes, P. The neutrophil in vascular inflammation. Nat. Med. 17, 1381-1390 (2011).
44. Beril Gok, H. et al. Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats. J. Clin. Neurosci. 14, 138-142 (2007).
45. Ibrahim-Zada, I., Rhee, P., Gomez, C. T., Weller, J. & Friese, R. S. Inhibition of sepsis-induced inflammatory response by beta1-adrenergic antagonists. J. Trauma Acute Care Surg. 76, 320-327 discussion 327-328 (2014).
46. Dunzendorfer, S. & Wiedermann, C. J. Modulation of neutrophil migration and superoxide anion release by metoprolol. J. Mol. Cell Cardiol. 32, 915-924 (2000).
47. Jaboureck-Bouttier, R. et al. Effects of two antihypertensive agents, labetalol and metoprolol, on the production of reactive oxygen species by normal polymorphonuclear leukocytes in vitro. Hypertens. Pregnancy 18, 239-247 (1999).
48. Srivastava, K. C. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets. Prostaglandins Leukot. Med. 29, 79-84 (1987).
49. Celik, T. et al. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol. Int. J. Cardiol. 116, 206-211 (2007).
50. Investigators, A.A. et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 297, 43-51 (2007).
51. Granger, C. B. et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation 108, 1184-1190 (2003).
52. Faxon, D. P. et al. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J. Am. Coll. Cardiol. 40, 1199-1204 (2002).
53. Faust, N., Varas, F., Kelly, L. M., Heck, S. & Graf, T. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 96, 719-726 (2000).
54. Garcia-Prieto, J. et al. beta3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. Basic Res. Cardiol. 109, 422 (2014).
55. Villablanca, E. J. et al. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat. Med. 16, 98-105 (2010).